Comprehensive review regarding the association of E2Fs with the prognosis and immune infiltrates in human head and neck squamous cell carcinoma

• Published in: Asian journal of surgery Vol. 47; no. 5; pp. 2106 - 2121
• Main Authors: Du, Wei, Xia, Xueming, Gou, Qiheng, Xie, Yuxin, Gao, Lanyang
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.05.2024; Elsevier
• Subjects: Biomarkers, Tumor - genetics; Biomarkers, Tumor - metabolism; CD8-Positive T-Lymphocytes - immunology; E2F transcription factors; E2F Transcription Factors - genetics; E2F Transcription Factors - metabolism; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms - genetics; Head and Neck Neoplasms - immunology; Head and Neck Neoplasms - mortality; Head and Neck Neoplasms - pathology; Head and neck squamous cell carcinoma; Humans; Lymphocytes, Tumor-Infiltrating - immunology; Neoplasm Staging; Prognosis; Squamous Cell Carcinoma of Head and Neck - genetics; Squamous Cell Carcinoma of Head and Neck - immunology; Squamous Cell Carcinoma of Head and Neck - mortality; Squamous Cell Carcinoma of Head and Neck - pathology; Head and neck squamous cell carcinoma; E2F transcription factors; Prognosis
• ISSN: 1015-9584; 0219-3108
• DOI: 10.1016/j.asjsur.2024.01.130

E2F transcription factors (E2Fs) are a group of genes that encode a family of transcription factors. They have been identified as being involved in the tumor progression of various cancer types. However, little is known about the expression level, genetic variation, molecular mechanism, and prognostic value and immune infiltration of different E2Fs in HNSCC.In this study, we utilized multiple databases to investigate the mRNA expression level, genetic alteration, and biological function of E2Fs in HNSCC patients. Then, the relationship between E2Fs expression and its association with the occurrence, progress, prognosis, and immune cell infiltration in patients with HNSCC was evaluated. We found that all eight E2Fs were higher expressed in HNSCC tissues than in normal tissues, and the expression levels of E2F1/2/3/4/5/6/8 were also associated with the stage and grade of HNSCC. The abnormal expression of E2F1/2/4/8 in HNSCC patients is related to the clinical outcome. The expression of E2Fs was statistically correlated with the immune cell infiltration in HNSCC and the infiltration of B cells and CD8+ T cells were positively associated with better OS in HNSCC patients. Furthermore, we verified the E2F2 at the tissue level in the validation experiment. Our study may provide novel insights into the choice of immunotherapy targets and potential prognostic biomarkers in HNSCC patients.